ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,242,000 | -28.8% | 414,277 | -19.4% | 0.00% | -25.0% |
| Q2 2023 | $15,798,000 | +18.0% | 513,898 | +38.3% | 0.00% | 0.0% |
| Q1 2023 | $13,387,000 | -7.7% | 371,549 | +1.2% | 0.00% | 0.0% |
| Q4 2022 | $14,508,000 | -2.4% | 367,116 | -0.8% | 0.00% | -20.0% |
| Q3 2022 | $14,872,000 | -4.0% | 370,133 | +0.4% | 0.01% | 0.0% |
| Q2 2022 | $15,491,000 | -19.2% | 368,492 | -25.1% | 0.01% | 0.0% |
| Q1 2022 | $19,174,000 | +7.7% | 492,142 | +10.2% | 0.01% | +25.0% |
| Q4 2021 | $17,802,000 | +16.4% | 446,712 | +5.5% | 0.00% | 0.0% |
| Q3 2021 | $15,297,000 | +5.2% | 423,262 | +19.3% | 0.00% | 0.0% |
| Q2 2021 | $14,539,000 | +150.6% | 354,735 | +166.8% | 0.00% | +100.0% |
| Q1 2021 | $5,801,000 | +901.9% | 132,964 | +1050.4% | 0.00% | – |
| Q4 2020 | $579,000 | +103.9% | 11,558 | +72.2% | 0.00% | – |
| Q3 2020 | $284,000 | +67.1% | 6,712 | +92.5% | 0.00% | – |
| Q2 2020 | $170,000 | – | 3,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |